Sagimet Biosciences (SGMT) stock gains as the company's new licensing deal with Teva (TEVA) targets Madrigal Pharma’s (MDGL) ...
Discover how AI, flow chemistry, and NMR come together in the PiPAC project to revolutionize scalable and autonomous API ...
License Agreement grants Sagimet a global, exclusive license to innovative forms of resmetirom active pharmaceutical ingredient (API) developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results